Melatonin Prevents Tumor Growth: The Role of Genes Controlling the Circadian Clock, the Cell Cycle, and Angiogenesis

Skarleth Cardenas-Romero1, Nadia Saderi1, Oscar Daniel Ramirez-Plascencia1

  • 1Laboratorio de Neuroanatomía Funcional y Ritmos Biológicos, Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.

PubMed

Insights

Melatonin may fight cancer by regulating genes involved in circadian rhythms and blood vessel growth. This study shows melatonin inhibits tumor growth in a model of circadian disruption.

Area of Science:

  • Chronobiology
  • Oncology
  • Molecular Biology

Background:

  • Melatonin, a hormone regulating sleep-wake cycles, shows protective effects against various diseases, including cancer.
  • Exposure to light at night disrupts melatonin synthesis, potentially increasing cancer risk, especially in shift workers.
  • Melatonin has demonstrated inhibitory effects on tumor cell proliferation, including glioblastoma-like stem cells.

Purpose of the Study:

  • To investigate the impact of melatonin on gene expression related to circadian rhythm, cell cycle, and angiogenesis in a rat model of circadian disruption.
  • To determine if melatonin administration can counteract the effects of constant light exposure on tumor growth and vascularization.

Main Methods:

  • Rats were exposed to constant light to model circadian disruption.
  • Melatonin was administered to assess its effects on tumor growth, vascularization, and gene expression.
  • Quantitative analysis of gene expression for key regulators of circadian rhythms (Per2), cell cycle (p53), and angiogenesis (VEGF-A, PDGF-C, Ang, TNF-α) was performed.

Main Results:

  • Melatonin administration significantly inhibited tumor growth in rats exposed to constant light.
  • Melatonin reduced tumor vascularization, a process often enhanced by circadian rhythm disturbance.
  • Molecular analysis revealed that melatonin modulated the circadian expression of genes critical for tumor biology, including p53, TNF-α, Per2, VEGF-A, PDGF-C, and Ang.

Conclusions:

  • Circadian disruption contributes to tumor progression, and melatonin can exert oncostatic effects.
  • Melatonin's anticancer mechanisms involve modulating circadian gene expression and inhibiting angiogenesis.
  • Melatonin shows potential as a therapeutic agent for cancers linked to circadian rhythm disruption.

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K